Who is sponsoring NCT00893048?

NCT00893048 is sponsored by Milton S. Hershey Medical Center.

What condition does NCT00893048 study?

NCT00893048 studies Cellulitis, Erysipelas.

What drugs are being tested in NCT00893048?

Interventions: Prednisone, Placebo Oral Tablet.

What is the status of NCT00893048?

NCT00893048 is currently WITHDRAWN.

Last reviewed 2017-07-25 · How we verify

The Use of Oral Steroids in the Treatment of Cellulitis

NCT00893048 PHASE2 WITHDRAWN

The prevalence of cellulitis in society is very high, as much as 3% of visits to Emergency Departments are for the treatment of this disease. The treatment of cellulitis varies depending on the severity. Low severity cases are treated with pain control and antibiotics by mouth and high severity are treated with antibiotics intravenously and pain control. The investigator's hypothesis is to see if the addition of steroids, which are known to decrease inflammation, will decrease the length of the disease process. If so, it will decrease the length of stay if IV antibiotics are needed, it will decrease duration of days out of work and decrease the overall pain control required and therefore patient satisfaction.

Details

Lead sponsor	Milton S. Hershey Medical Center
Phase	PHASE2
Status	WITHDRAWN
Start date	Fri Jan 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Cellulitis
Erysipelas

Interventions

Prednisone
Placebo Oral Tablet